XML 17 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Net interest income:                      
Interest income from commercial mortgage loans $ 75,275 $ 71,179 $ 65,141 $ 52,114 $ 45,942 $ 41,203 $ 37,089 $ 34,398 $ 263,709 $ 158,632 $ 102,927
Interest income from subordinate loans 34,944 37,308 34,075 33,853 43,993 47,268 39,640 34,390 140,180 165,291 122,394
Interest income from securities 0 0 0 0 1,219 2,625 4,700 6,054 0 14,598 39,055
Interest expense (32,413) (31,007) (28,437) (22,740) (21,967) (19,855) (19,205) (17,030) (114,597) (78,057) (63,759)
Net interest income 77,806 77,480 70,779 63,227 69,187 71,241 62,224 57,812 289,292 260,464 200,617
Operating expenses:                      
General and administrative expenses (includes equity-based compensation of $13,588 in 2018, $13,314 in 2017, and $7,090 in 2016) (3,977) (5,843) (5,652) (4,998) (5,138) (4,629) (5,200) (5,758) (20,470) (20,725) (24,983)
Management fees to related party (9,804) (9,515) (9,013) (8,092) (8,169) (8,309) (7,742) (7,432) (36,424) (31,652) (23,388)
Total operating expenses (13,781) (15,358) (14,665) (13,090) (13,307) (12,938) (12,942) (13,190) (56,894) (52,377) (48,371)
Loss from unconsolidated joint venture 0 0 0 0 0 0 (3,305) 458 0 (2,847) (96)
Other income 465 427 343 203 229 359 244 108 1,438 940 1,094
Provision for loan losses and impairments (15,000) 0 (5,000) 0 0 0 (5,000) 0 (20,000) (5,000) (15,000)
Realized gain (loss) on sale of assets 0 0 0 0 (37,575) (4,076) 0 (1,042) 0 (42,693) 3,834
Unrealized gain (loss) on securities 0 0 0 0 25,335 13,488 (4,510) 2,852 0 37,165 (26,099)
Foreign currency gain (loss) (6,761) (4,050) (29,649) 10,125 658 7,763 6,913 3,172 (30,335) 18,506 (29,284)
Bargain purchase gain                 0 0 40,021
Loss on early extinguishment of debt 0 (2,573) 0 0 (1,947) 0 0 0 (2,573) (1,947) 0
Gain (loss) on derivative instruments (includes unrealized gains (losses) of $29,345 in 2018, $(11,523) in 2017, and $2,608 in 2016) 10,261 6,291 33,538 (11,032) (1,265) (7,481) (7,389) (3,045) 39,058 (19,180) 31,160
Net income 52,990 62,217 55,346 49,433 41,315 68,356 36,235 47,125 219,986 193,031 157,876
Preferred dividends (6,835) (6,836) (6,834) (6,835) (6,993) (11,148) (9,310) (9,310) (27,340) (36,761) (30,295)
Net income available to common stockholders $ 46,155 $ 55,381 $ 48,512 $ 42,598 $ 34,322 $ 57,208 $ 26,925 $ 37,815 $ 192,646 $ 156,270 $ 127,581
Net income per share of common stock:                      
Basic (in dollars per share) $ 0.34 $ 0.42 $ 0.39 $ 0.38 $ 0.32 $ 0.54 $ 0.28 $ 0.41 $ 1.52 $ 1.54 $ 1.74
Diluted (in dollars per share) $ 0.34 $ 0.40 $ 0.39 $ 0.38 $ 0.32 $ 0.54 $ 0.28 $ 0.41 $ 1.48 $ 1.54 $ 1.74
Basic weighted average shares of common stock outstanding (in shares) 133,852,915 129,188,343 123,019,993 110,211,853 106,721,887 105,446,704 95,428,134 91,612,447 124,147,073 99,859,153 72,371,374
Diluted weighted average shares of common stock outstanding (in shares) 163,900,633 153,918,435 124,629,317 111,871,429 108,095,950 106,812,721 96,796,289 92,998,250 153,821,515 101,232,610 73,305,101